Principal Investigator
Beatrice Madrazo
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220258
Clinical Trial Summary
A Multicentre, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment
Phase
Phase III
Funding Agency/Sponsor
Disease
Pancreatic, Liver, and Related Cancers
Contact Information
Phone Number
+1 (305) 2434639